The typical future-tech scenario calls for millions of low-powered radio frequency devices scattered throughout our environment – from factory-floor sensor arrays to medical implants to smart devices for battlefields.
Because of the short and unpredictable lifespans of chemical batteries, however, regular replacements would be required to keep these devices humming. Fuel cells and solar cells require little maintenance, but the former are too expensive for such modest, low-power applications, and the latter need plenty of sun.
A third option, though, may provide a powerful – and safe – alternative. It’s called the Direct Energy Conversion (DEC) Cell, a betavoltaics-based “nuclear” battery that can run for over a decade on the electrons generated by the natural decay of the radioactive isotope tritium. It’s developed by researchers at the University of Rochester and a startup, BetaBatt, in a project described in the May 13 issue of Advanced Materials and funded in part by the National Science Foundation.
Because tritium’s half-life is 12.3 years (the time in which half of its radioactive energy has been emitted), the DEC Cell could provide a decade’s worth of power for many applications. Clearly, that would be an economic boon – especially for applications in which the replacement of batteries is highly inconvenient, such as in medicine and oil and mining industries, which often place sensors in dangerous or hard-to-reach locations.
“One of our main markets is for remote, very difficult to replace sensors,” says Larry Gadeken, chief inventor and president of BetaBatt. “You could place this [battery] once and leave it alone.”
Betavoltaic devices use radioisotopes that emit relatively harmless beta particles, rather than more dangerous gamma photons. They’ve actually been tested in labs for 50 years – but they generate so little power that a larger commercial role for them has yet to be found. So far, tritium-powered betavoltaics, which require minimal shielding and are unable to penetrate human skin, have been used to light exit signs and glow-in-the-dark watches. A commercial version of the DEC Cell will likely not have enough juice to power a cell phone – but plenty for a sensor or pacemaker.
The key to making the DEC Cell more viable is increasing the efficiency with which it creates power. In the past, betavoltaics researchers have used a design similar to a solar cell: a flat wafer is coated with a diode material that creates electric current when bombarded by emitted electrons. However, all but the electron particles that shoot down toward the diodes are lost in that design, says University of Rochester professor of electrical and computer engineering Phillipe Fauchet, who developed the more-efficient design based on Gadeken’s concept.
The solution was to expose more of the reactive surface to the particles by creating a porous silicon diode wafer sprinkled with one-micron wide, 40 micron-deep pits. When the radioactive gas occupies these pits, it creates the maximum opportunity for harnessing the reaction.
As importantly, the process is easily reproducible and cheap, says Fauchet – a necessity if the DEC Cell is to be commercially viable.
The fabrication techniques may be affordable, but the tritium itself – a byproduct of nuclear power production – is still more expensive than the lithium in your cell-phone battery. The cost is less of an issue, however, for devices designed specifically to collect hard-to-get data.
Cost is only one reason why Gadeken says he will not pursue the battery-hungry consumer electronics market. Other issues include the regulatory and marketing obstacles posed by powering mass-market devices with radioactive materials and the large battery size that would be required to generate sufficient power. Still, he says, the technology might some day be used as a trickle-recharging device for lithium-ion batteries.
Instead, his company is targeting market sectors that need long-term battery power and have a comfortable familiarity with nuclear materials.
“We’re targeting applications such as medical technology, which are already using radioactivity,” says Gadeken.
For instance, many implant patients continue to outlive their batteries and require costly and risky replacement surgery.
Eventually, Gadeken hopes to serve NASA as well, if the company can find a way to extract enough energy from tritium to power a space-faring object. Space agencies are interested in safer and lighter power sources than the plutonium-powered Radioisotope Thermal Generators (RTG) used in robotic missions, such as Voyager, which has an RTG power source that is intended to run until around 2020.
Furthermore, a betavoltaics power source would likely alleviate environmental concerns, such as those voiced at the launch of the Cassini satellite mission to Saturn, when protestors feared that an explosion might lead to fallout over Florida.
For now, though, Gadeken hopes to interest the medical field and a variety of niche markets in sub-sea, sub-surface, and polar sensor applications, with a focus on the oil industry.
And the next step is to adapt the technology for use in very tiny batteries that could power micro-electro-mechanical Systems (MEMS) devices, such as those used in optical switches or the free-floating “smart dust” sensors being developed by the military.
In fact, another betavoltaics device, under development at Cornell University, is also targeting the MEMS power market. The Radioisotope-Powered Piezoelectric Generator, due in prototype form in a few years, will combine a betavoltaics cell with a tritium-powered electromechanical cantilever device first demonstrated in 2002.
Amit Lal, one of the Cornell researchers, offers both praise and cautious skepticism about the DEC Cell. While he’s impressed with the power output from the DEC Cell, he said that there are still issues with power leakage. To avoid those potential leakage problems, Cornell is using a slightly larger-scale wafer design. They’re also planning to move to a porous design and either solid or liquid tritium to improve efficiency.
Lal also notes that the market for either Cornell’s device or the DEC Cell might be squeezed by newer, longer-lasting lithium batteries. Still, there’s a niche for very small devices, he believes, especially those that must run longer than ten years.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.